Comparative study of antibacterial activity of cefazolin sodium and of its crystalline modifications

International Journal of Pharmaceutics

Volumn 189, Issue 2, 1999, Pages 235-240

  Opalchenova, G ^a   Kalinkova, G N ^b  

^a National Drug Institute   (Bulgaria)

^b MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Antibacterial activity; Antibiotics; Cefazolin sodium; Crystalline modifications; H bonds

Indexed keywords

ACETONITRILE; CEFAZOLIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CRYSTAL; DRUG FORMULATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HYDROGEN BOND; INFRARED SPECTROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

CEFAZOLIN; CEPHALOSPORINS; CRYSTALLIZATION; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; SPECIES SPECIFICITY;

EID: 0032874685     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00259-8     Document Type: Article

References (22)

1. Bartlett J.G. Update in infectious diseases. Ann. Int. Med. 126:1997;48-56.
2. Borka L., Haleblian J.K. Crystal polymorphism of pharmaceuticals. Acta Pharm. Jugosl. 40:1990;71-84.
3. Bernabei M.T., Forni F., Coppi G., Iannuccelli V., Cameroni R. Cristallinita ed equivalenza nel cloramfenicolo palmitato. Farmaco. 11:1983;391-402.
4. Cameroni R., Coppi G., Forni F., Gamberini G., Ferioli V. Pseudomorphosi nel cloramfenicolo stearato e palmitato in relazione alla disponibilita. Farmaco. 4:1983;173-182.
5. Cormican, M.G., Jones, R.N., 1996. Emerging resistance to antimicrobial agents in Gram-positive bacteria: Enterococci, Staphylococci and Nonpneumococcal Streptococci. Drugs (Suppl. Preprint) 6-12.
6. European Pharmacopoea, 1997. Council of Europe, Strasbourg, 2.6.12.
7. Eichenwald H.F. Antimicrobial therapy in infants and children: Update 1976-1985. Part 1. J. Pediatr. 107:1985;161-168.
8. Grunenberg A., Henck J.O., Siesler H.W. Theoretical derivation and practical application of energy/temperature diagrams as an instrument in preformulation studies of polymorphic drug substances. Int. J. Pharm. 129:1996;147-158.
9. Haleblian J.K., McCrone Pharmaceutical applications of polymorphism. J. Pharm. Sci. 58:1969;911-929.
10. Hume E.B.H., Willcox M.D.P., Sweeney D.F., Holden B.A. An examination of the clonal variants of Serratia marcescens that infect the eye during contact lens wear. J. Med. Microbiol. 45:1996;127-132.
11. Jett B.D., Ritchie D.J., Reichley R., Bailey T.C., Sahm D.F. In vitro activities of various β-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oximino cephalosporins. Antimicrob. Agents Chemother. 39:1995;1187-1190.
12. Kalinkova G., Dimitrova L. Infrared spectroscopic studies of the antibiotic cefamandole nafate. Vibrational Spectroscopy. 10:1995;41-47.
13. Kalinkova G., Ovcharova G., Gagauzov I., Krestev V., Petrov L. Comparative IR-spectral studies of different modifications of the antibiotic Cefazolin Na. J. Mol. Struct. 219:1990;329-334.
14. Khan A.A., Cerniglia C.E. Detection of Pseudomonas aeruginosa from clinical and environmental samples by amplification of the exotoxin A gene using PCR. Appl. Environ. Microbiol. 60:1994;3739-3745.
15. National Committee for Clinical Laboratory Standards, 1993a. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. NCCLS, Villanova, PA.
16. National Committee for Clinical Laboratory Standards, 1993b Performance standards for antimicrobial disk susceptibilty tests. Approved standard M2-A5 (5th ed.), NCCLS, Villanova, PA.
17. Opalchenova G., Kalinkova G. Evaluation of new polymorph azlocillin sodium by its bacterial activity. Int. J. Pharm. 153:1997;263-265.
18. Pikal M.J., Lukes A.L., Lang J.E., Gaines K. Quantitative crystallinity determinations for β lactam antibiotics by solution calorimetry:correlations with stability. J. Pharm. Sci. 67:1978;767-773.
19. Schulz M., Schmoldt A. Therapeutic and toxic blood concentrations of more than 500 drugs. Pharmazie. 52:1997;895-911.
20. Thoma K., Serno P. Physical instability of drugs as a result of polymorphic changes in the crystal structure. Dtch. Apoth. Ztg. 124:1984;2162-2170.
21. United States Pharmacopoeia, 1993 (71)1687.
22. Underwood E. Ecology of microoganisms as it affect the pharmaceutical industry. Hugo W.B., Russell A.D. Pharmaceutical Microbiology. 4:1987;343-359 Blackwell, Oxford.